Responsiveness of HIV-specific CD4 T cells to PD-1 blockade

Defining the T helper functions impaired by programmed death–1 (PD-1) is crucial for understanding its role in defective HIV control and determining the therapeutic potential of targeting this inhibitory pathway. We describe here the relationships among disease stage, levels of PD-1 expression, and...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 118; no. 4; pp. 965 - 974
Main Authors Porichis, Filippos, Kwon, Douglas S., Zupkosky, Jennifer, Tighe, Daniel P., McMullen, Ashley, Brockman, Mark A., Pavlik, David F., Rodriguez-Garcia, Marta, Pereyra, Florencia, Freeman, Gordon J., Kavanagh, Daniel G., Kaufmann, Daniel E.
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 28.07.2011
Americain Society of Hematology
American Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Defining the T helper functions impaired by programmed death–1 (PD-1) is crucial for understanding its role in defective HIV control and determining the therapeutic potential of targeting this inhibitory pathway. We describe here the relationships among disease stage, levels of PD-1 expression, and reversibility of CD4 T-cell impairment. PD-L1 blockade in vitro enhanced HIV-specific production of Th0 (IL-2), Th1 (IFN-γ), Th2 (IL-13), and TFH (IL-21) cytokines by CD4 T cells. PD-L1 blockade caused an early increase in cytokine transcription and translation that preceded cell proliferation. Although the impact of PD-L1 blockade on cytokine expression and, to a lesser extent, cell proliferation was associated with markers of disease progression, restoration of cytokine secretion was also observed in most subjects with undetectable viremia. PD-L1 blockade restored cytokine secretion in both PD-1intermediate and PD-1high sorted CD4 T-cell subsets. Compared with PD-1high HIV-specific CD8 T cells, PD-1high HIV-specific CD4 T cells showed lower expression of the inhibitory molecules CD160 and 2B4, demonstrating marked differences in expression of inhibitory receptors between T-cell subsets. These data show that PD-1 impairs HIV-specific T helper responses both by limiting expansion of these cells and by inhibiting effector functions of multiple differentiated CD4 T-cell subsets.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-4971
1528-0020
1528-0020
DOI:10.1182/blood-2010-12-328070